C Resveratrol multimers with selective inhibitory of genome replication of HCV and use thereof

摘要

The present invention relates to a resveratrol oligomer having selective inhibitory activity of genomic replication of hepatitis C virus and its use, and more particularly, to a resveratrol oligomer having resveratrol having selective inhibitory activity of genomic replication of hepatitis C virus, And a pharmaceutical composition for preventing or treating hepatitis C comprising the same. The resveratrol oligomer according to the present invention has a very low toxicity to hepatocytes and has an excellent effect of selectively inhibiting the genomic replication of hepatitis C virus so that the pharmaceutical composition for preventing, It is expected that the composition can be usefully used as an active ingredient of an active composition or a functional food composition.